Parametric Portfolio Associates’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-193,848
| Closed | -$659K | – | 4027 |
|
|
2018
Q3 | $659K | Sell |
193,848
-168,661
| -47% | -$608K | ﹤0.01% | 3305 |
|
|
2018
Q2 | $1.36M | Buy |
362,509
+89,528
| +33% | +$436K | ﹤0.01% | 2898 |
|
|
2018
Q1 | $1.12M | Sell |
272,981
-52,405
| -16% | -$244K | ﹤0.01% | 2960 |
|
|
2017
Q4 | $1.51M | Buy |
325,386
+133,536
| +70% | +$736K | ﹤0.01% | 2788 |
|
|
2017
Q3 | $1.36M | Sell |
191,850
-2,288
| -1% | -$16.5K | ﹤0.01% | 2844 |
|
|
2017
Q2 | $1.4M | Buy |
194,138
+1,156
| +0.6% | +$7.22K | ﹤0.01% | 2784 |
|
|
2017
Q1 | $1.19M | Buy |
192,982
+72,436
| +60% | +$397K | ﹤0.01% | 2775 |
|
|
2016
Q4 | $706K | Buy |
120,546
+96,842
| +409% | +$529K | ﹤0.01% | 3017 |
|
|
2016
Q3 | $126K | Sell |
23,704
-2,247
| -9% | -$12.1K | ﹤0.01% | 3649 |
|
|
2016
Q2 | $172K | Buy |
25,951
+1,328
| +5% | +$7.42K | ﹤0.01% | 3645 |
|
|
2016
Q1 | $115K | Sell |
24,623
-1,533
| -6% | -$6.12K | ﹤0.01% | 3847 |
|
|
2015
Q4 | $132K | Buy |
26,156
+5,210
| +25% | +$24.8K | ﹤0.01% | 3823 |
|
|
2015
Q3 | $74K | Sell |
20,946
-28,616
| -58% | -$192K | ﹤0.01% | 3215 |
|
|
2015
Q2 | $495K | Sell |
49,562
-15,776
| -24% | -$169K | ﹤0.01% | 3286 |
|
|
2015
Q1 | $832K | Buy |
65,338
+13,300
| +26% | +$171K | ﹤0.01% | 2926 |
|
|
2014
Q4 | $736K | Sell |
52,038
-1,514
| -3% | -$23.5K | ﹤0.01% | 3014 |
|
|
2014
Q3 | $736K | Sell |
53,552
-13,467
| -20% | -$206K | ﹤0.01% | 2927 |
|
|
2014
Q2 | $1.03M | Sell |
67,019
-3,226
| -5% | -$45.7K | ﹤0.01% | 2686 |
|
|
2014
Q1 | $1.2M | Buy |
70,245
+1,477
| +2% | +$22.3K | ﹤0.01% | 2527 |
|
|
2013
Q4 | $891K | Buy |
68,768
+17,039
| +33% | +$203K | ﹤0.01% | 2755 |
|
|
2013
Q3 | $522K | Buy |
51,729
+16,155
| +45% | +$144K | ﹤0.01% | 3067 |
|
|
2013
Q2 | $266K | Buy |
+35,574
| New | +$278K | ﹤0.01% | 3333 |
|
Parametric Portfolio Associates's KERX Position: Q4 2018 in Review
Parametric Portfolio Associates sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 193,848 shares — an estimated $659K sold.
Parametric Portfolio Associates first reported a position in KERX in Q2 2013 and held it in 22 quarters. The position peaked at $1.51M in Q4 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Parametric Portfolio Associates reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Parametric Portfolio Associates sold 193,848 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $659K.
- Parametric Portfolio Associates first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
- Parametric Portfolio Associates's Keryx Biopharmaceuticals Inc position peaked at $1.51M in Q4 2017.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Parametric Portfolio Associates's 13F filing for Q4 2018, filed 14 Feb 2019.